Recent Updates
Recently added Catalysts
MYO Positive Sentiment

Myomo at H.C. Wainwright 27th Global Conference

Tuesday, September 2, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Myomo, Inc. will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025. CEO Paul Gudonis and CFO David Henry will represent the company, which focuses on wearable robotics for individuals with neurological disorders. A presentation will be available on demand, and management will hold virtual meetings with investors.
Price reaction · baseline $1.0393 (2025-09-02T16:28:00.000Z) · hit during market hours · clean, no other MYO news in the window
day 0 close · peak
+2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Myomo is participating in a prominent investment conference.
  • The company is showcasing its innovative wearable medical robotics.
  • Management will engage directly with investors through virtual meetings.

Full Press Release Details

BURLINGTON, Mass. (September 2, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright 27 th Annual Global Investment Conference taking place September 8-10, 2025 at the Lotte New York Palace Hotel. A Company presentation will be available on demand for conference participants and management will be available for virtual one-on-one meetings with investors registered for the event. Read More .

Frequently Asked Questions

When is Myomo presenting at the conference?

Myomo will present at the H.C. Wainwright Conference from September 8-10, 2025.

Who will represent Myomo at the conference?

Paul Gudonis and David Henry will represent Myomo at the conference.

Will there be opportunities for investor meetings?

Yes, management will be available for virtual one-on-one meetings with registered investors.

What does Myomo specialize in?

Myomo specializes in wearable medical robotics for individuals with upper-limb paralysis.

ShareAdd on Google
Tags: MYO Viatris Investor Conferences Healthcare Myomo H.C. Wainwright investment conference wearable robotics neurological disorders
Last updated: Sep 2, 2025

Biotech snapshot

Cash runway
$13M liquidity · $1M/mo burn
~20 mo
Low dilution risk